Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 140,000 shares at $43.12 ($5.9M) on 2025-08-06, disclosed to the SEC on 2025-08-08.
Scheduled sale ($5.9M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.24 | 38,500 | $1.5M | 26.3% |
| 2 | $42.00 | 38,000 | $1.6M | 27.1% |
| 3 | $43.12 | 63,500 | $2.7M | 46.5% |
| Total | $42.02 avg | 140,000 | $5.9M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |